Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment

Fig. 2

Time-dependent ROC analysis, survival outcome analysis and Kaplan- Meier analysis and risk score analysis for the IRGPI accurately predicts survival of MM patients in LR and HR. A Kaplan–Meier curve of the prognostic model in the training cohort the validation cohorts, B Time-dependent ROC curves analyses of the model in all cohorts, C Risk score distribution of the prognostic model on the training cohort the validation cohorts

Back to article page